We built immunohistochemical staining of a tissue microarray containing data from 100 patients with colorectal cancer at the protein level and found that POU4F1, DNASE1L2, and WDR72 in the signature were significantly upregulated, and correlated with poor prognosis with a potential therapeutic target strategy. The gene discussed is DNASE1L2; the disease is colorectal cancer.